IPSEY
Price
$34.85
Change
+$1.14 (+3.38%)
Updated
Sep 5 closing price
Capitalization
11.56B
46 days until earnings call
LVRLF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
6.46M
58 days until earnings call
Interact to see
Advertisement

IPSEY vs LVRLF

Header iconIPSEY vs LVRLF Comparison
Open Charts IPSEY vs LVRLFBanner chart's image
Ipsen S.A
Price$34.85
Change+$1.14 (+3.38%)
Volume$1.47K
Capitalization11.56B
CordovaCann
Price$0.06
Change-$0.00 (-0.00%)
Volume$4.7K
Capitalization6.46M
IPSEY vs LVRLF Comparison Chart in %
Loading...
IPSEY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LVRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPSEY vs. LVRLF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPSEY is a Buy and LVRLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (IPSEY: $34.85 vs. LVRLF: $0.06)
Brand notoriety: IPSEY and LVRLF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: IPSEY: 167% vs. LVRLF: 29%
Market capitalization -- IPSEY: $11.56B vs. LVRLF: $6.46M
IPSEY [@Pharmaceuticals: Generic] is valued at $11.56B. LVRLF’s [@Pharmaceuticals: Generic] market capitalization is $6.46M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPSEY’s FA Score shows that 2 FA rating(s) are green whileLVRLF’s FA Score has 0 green FA rating(s).

  • IPSEY’s FA Score: 2 green, 3 red.
  • LVRLF’s FA Score: 0 green, 5 red.
According to our system of comparison, IPSEY is a better buy in the long-term than LVRLF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPSEY’s TA Score shows that 5 TA indicator(s) are bullish while LVRLF’s TA Score has 4 bullish TA indicator(s).

  • IPSEY’s TA Score: 5 bullish, 4 bearish.
  • LVRLF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both IPSEY and LVRLF are a good buy in the short-term.

Price Growth

IPSEY (@Pharmaceuticals: Generic) experienced а +2.41% price change this week, while LVRLF (@Pharmaceuticals: Generic) price change was -1.92% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

IPSEY is expected to report earnings on Oct 22, 2025.

LVRLF is expected to report earnings on Nov 03, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IPSEY($11.6B) has a higher market cap than LVRLF($6.46M). LVRLF YTD gains are higher at: 47.125 vs. IPSEY (21.901).
IPSEYLVRLFIPSEY / LVRLF
Capitalization11.6B6.46M179,511%
EBITDA1.3BN/A-
Gain YTD21.90147.12546%
P/E Ratio22.26N/A-
Revenue3.76BN/A-
Total Cash1.45BN/A-
Total Debt869MN/A-
FUNDAMENTALS RATINGS
IPSEY vs LVRLF: Fundamental Ratings
IPSEY
LVRLF
OUTLOOK RATING
1..100
2727
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
97
Overvalued
PROFIT vs RISK RATING
1..100
40100
SMR RATING
1..100
91100
PRICE GROWTH RATING
1..100
4961
P/E GROWTH RATING
1..100
13100
SEASONALITY SCORE
1..100
65n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IPSEY's Valuation (31) in the null industry is significantly better than the same rating for LVRLF (97). This means that IPSEY’s stock grew significantly faster than LVRLF’s over the last 12 months.

IPSEY's Profit vs Risk Rating (40) in the null industry is somewhat better than the same rating for LVRLF (100). This means that IPSEY’s stock grew somewhat faster than LVRLF’s over the last 12 months.

IPSEY's SMR Rating (91) in the null industry is in the same range as LVRLF (100). This means that IPSEY’s stock grew similarly to LVRLF’s over the last 12 months.

IPSEY's Price Growth Rating (49) in the null industry is in the same range as LVRLF (61). This means that IPSEY’s stock grew similarly to LVRLF’s over the last 12 months.

IPSEY's P/E Growth Rating (13) in the null industry is significantly better than the same rating for LVRLF (100). This means that IPSEY’s stock grew significantly faster than LVRLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IPSEYLVRLF
RSI
ODDS (%)
Bearish Trend 1 day ago
68%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
51%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
57%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
56%
Bullish Trend 1 day ago
70%
Advances
ODDS (%)
Bullish Trend 10 days ago
53%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
43%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
47%
Bullish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
IPSEY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LVRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ADIV18.150.19
+1.05%
SmartETFs Asia Pcfc Dvdnd Bldr ETF
PZA22.560.23
+1.03%
Invesco National AMT-Free Muni Bd ETF
SPHB105.260.35
+0.33%
Invesco S&P 500® High Beta ETF
SEPP29.46-0.03
-0.11%
PGIM S&P 500 Buffer 12 ETF - Sep
HIPS12.23-0.07
-0.57%
GraniteShares HIPS US High Income ETF

IPSEY and

Correlation & Price change

A.I.dvisor tells us that IPSEY and LBTSF have been poorly correlated (+15% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IPSEY and LBTSF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSEY
1D Price
Change %
IPSEY100%
+3.39%
LBTSF - IPSEY
15%
Poorly correlated
N/A
LVRLF - IPSEY
9%
Poorly correlated
+1.96%
HYPMY - IPSEY
7%
Poorly correlated
+1.57%
IPSEF - IPSEY
6%
Poorly correlated
N/A
INDV - IPSEY
5%
Poorly correlated
+1.01%
More

LVRLF and

Correlation & Price change

A.I.dvisor tells us that LVRLF and GNMLF have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LVRLF and GNMLF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LVRLF
1D Price
Change %
LVRLF100%
+1.96%
GNMLF - LVRLF
20%
Poorly correlated
N/A
MCUJF - LVRLF
14%
Poorly correlated
N/A
IPSEY - LVRLF
9%
Poorly correlated
+3.39%
MEDIF - LVRLF
8%
Poorly correlated
-1.26%
KSPHF - LVRLF
5%
Poorly correlated
N/A
More